Intercepting pancreatic cancer development with mutant KRAS-targeted immunotherapy

被引：2
|
作者：
Zaidi, Neeha
Huff, Amanda
Marcisak-Davis, Emily
Haldar, Daniel
Heumann, Thatcher
Konig, Max
Mog, Brian
Montagne, Janelle
Longway, Gabriella
Andaloori, Lalitya
Lyman, Melissa
Danilova, Ludmila
Nauroth, Julie
Kagohara, Luciane
Fertig, Elana
Azad, Nilo
Jaffee, Elizabeth
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 22期
关键词：
D O I：
10.1158/1538-7445.PANCA22-IA013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA013
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune vulnerabilities of mutant KRAS in pancreatic cancer
    Cheng, Noah C.
    Vonderheide, Robert H.
    TRENDS IN CANCER, 2023, 9 (11) : 928 - 936
  • [22] An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
    Boumelha, Jesse
    Trecesson, Sophie de Carne
    Law, Emily K.
    Romero-Clavijo, Pablo
    Coelho, Matthew A.
    Ng, Kevin W.
    Mugarza, Edurne
    Moore, Christopher
    Rana, Sareena
    Caswell, Deborah R.
    Murillo, Miguel
    Hancock, David C.
    Argyris, Prokopios P.
    Brown, William L.
    Durfee, Cameron
    Larson, Lindsay K.
    Vogel, Rachel, I
    Suarez-Bonnet, Alejandro
    Priestnall, Simon L.
    East, Philip
    Ross, Sarah J.
    Kassiotis, George
    Molina-Arcas, Miriam
    Swanton, Charles
    Harris, Reuben
    Downward, Julian
    CANCER RESEARCH, 2022, 82 (19) : 3435 - 3448
  • [23] KRAS-targeted PROTAC degraders are broadly efficacious against KRAS-dependent tumor models
    Smith, Kathryn
    Lopez-Arroyo, Andrea
    Berk, Jason
    Hegan, Peter
    Nower, Peter
    Tice, Samantha
    Moutran, Aurelie
    Pizzano, Jennifer
    Dowtin, Amanda
    Bookbinder, Mark
    Bortolon, Elizabeth
    Cadelina, Greg
    Karim, Fazlul
    Digianantonio, Katie
    Bekes, Miklos
    Medina, Jesus
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [24] Hope for targeted treatment of KRAS-mutant lung cancer
    Crisp, Alisa
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) : 121 - 121
  • [25] Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer
    Liu, Xiaoxiao
    Li, Zhang
    Wang, Yuexiang
    ADVANCED BIOLOGY, 2021, 5 (03):
  • [26] Advances in immunotherapy and targeted therapy for pancreatic cancer
    Xiangyan Zhou
    Xiaohui Wang
    Shengli Yang
    Zaozao Huang
    Oncology and Translational Medicine, 2025, 11 (02) : 81 - 91
  • [27] Development of immunotherapy for pancreatic cancer
    Kawakami, Y
    Okada, T
    Akada, M
    PANCREAS, 2004, 28 (03) : 320 - 325
  • [28] Nucleotide metabolism heterogeneity in mutant KRAS pancreatic cancer.
    Le, Thuc M.
    Kim, Woosuk
    Capri, Joseph R.
    Cabebe, Anthony E.
    Armstrong, Wes
    Abt, Evan
    Poddar, Soumya
    Xu, Shili
    Dawson, Dave
    Donahue, Timothy R.
    Radu, Caius G.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 51 - 51
  • [29] Mutant KRAS downregulates LIFR to enhance glycolysis in pancreatic cancer
    Liu, Suhu
    Gandler, Helen I.
    Walker, Sarah R.
    Ye, Darwin Q.
    Giaccone, Zachary T.
    Nowak, Jonathan A.
    Aguirre, Andrew J.
    Wolpin, Brian M.
    Frank, David A.
    CANCER RESEARCH, 2019, 79 (24)
  • [30] KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment
    Zeitouni, Daniel
    Pylayeva-Gupta, Yuliya
    Der, Channing J.
    Bryant, Kirsten L.
    CANCERS, 2016, 8 (04)
12345